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Abstract The emergence of multicellular animals could only
takeplaceonceevolutionhadproducedmolecularmechanisms
for cell adhesion and communication. Today, all metazoans
express integrin-type adhesion receptors and receptors for
growth factors. Integrins recognize extracellular matrix pro-
teins and respective receptors on other cells and, following
ligand binding, can activate the same cellular signaling
pathways that are regulated by growth factor receptors. Recent
reports have indicated that the two receptor systems also
collaborate in many other ways. Here, we review the present
informationconcerning therole ofintegrinsasassisting growth
factor receptors and the interplay between the receptors in cell
signaling and in the orchestration of receptor recycling.
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Integrin family of adhesion receptors
The integrin family of cell adhesion receptors mediates the
anchoring of cell to the protein fibrils and networks that
compose the extracellular matrix (ECM). In addition,
certain members of the integrin family can bind to plasma
proteins or respective receptors on other cells. Based on
their structure and phylogeny, human integrin α subunits
can be divided into four categories (Johnson et al. 2009).
Basically, all metazoans seem to have integrins that
recognize arginine-glycine-aspartic acid (RGD) motifs in
their ligands. In vertebrates, they act as receptors for
ECM glycoproteins, such as fibronectin, vitronectin, and
fibrinogen. The classical fibronectin receptor, α5β1 integrin,
plays an important role during development, since mice
lacking α5β1 die early during embryonic development
(Yang et al. 1993). Integrin α8β1 is another fibronectin
receptor and is important for the development of the kidney
(Muller et al. 1997) and inner ear (Littlewood Evans and
Muller 2000). Platelet fibrinogen receptor, αIIbβ3 integrin,
is important for hemostasis, whereas the physiological role of
the five αV-containing heterodimers (αVβ1, αVβ3, αVβ5,
αVβ6, αVβ8) is less obvious. Deficiency of all five
receptors in αV-null animals causes a surprisingly mild
phenotype (Bader et al. 1998). The development of most
organs is close to normal, and some of the animals may be
born alive, although they die soon after birth because of
defects in their blood vessels (Bader et al. 1998). The
deficiency of αVβ8 integrin has been show to affect brain
vessel formation (Zhu et al. 2002). However, in general, the
role of αV integrins in angiogenesis has been under debate
since inhibitors of αV function can block angiogenesis in
animal models (Brooks et al. 1994), whereas the genetic
deletion of αVβ3a n dαVβ5 integrins actually promotes
angiogenesis (Reynolds et al. 2002). Furthermore, small
concentrations of RDG-mimetic integrin inhibitors may also
promote angiogenesis (Reynolds et al. 2009).
Laminin receptor integrins are also widespread in the
animal kingdom suggesting their early evolution. Integrin
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of the lung, kidney (Kreidberg et al. 1996), and skin
(DiPersio et al. 1997), whereas α6β4i n t e g r i ni sa n
essential component of hemidesmosomes (Dowling et al.
1996). Integrin β4 is exceptional when compared with all
other integrins because of its large intracellular part. In
addition to β4, α6 can have another β partner, namely β1
integrin. α7β1 is specific to muscles and, when genetically
defective, causes a type of muscular dystrophy in mice
(Mayer et al. 1997), whereas α7 mutations may lead to
congenital myopathy in man (Hayashi et al. 1998).
Integrins α4 and α9 can both form a heterodimer with
β1 integrin. In addition, α4 can have another β partner,
namely β7. Based on their structural features, the two α
subunits are considered to form a separate subgroup of
integrins (Johnson et al. 2009). Integrin α4 can bind to
fibronectin in ECM in an RGD-independent manner. It can
also mediate cell-cell interaction and act as a receptor for
VCAM (vascular cell adhesion molecule), which is a
transmembrane protein belonging to the immunoglobulin
superfamily. Integrin α4 is important for early steps of
embryonic development, and its deficiency causes embry-
onic lethality (Yang et al. 1995). Integrin α9β1 has several
ECM ligands, including tenascin C. Functionally, α9β1
integrin has been associated with the regulation of
lymphangiogenesis (Huang et al. 2000).
The fourth phylogenic subgroup of integrin α subunits is
composed of members that differ from all other integrin
subunits based on the finding that they contain an extra
domain in their structure. After the cloning of the integrin α
subunits, the extra domain was named an I domain, i.e., an
inserted domain. Later, the αI domain was realized to be
the ligand-binding domain in this subset of integrins. The
integrin αI domain takes a Rossmann fold and, therefore, is
similar to the von Willebrand factor A domain (Michishita
et al. 1993). Based on this finding, integrin I domains are
also called integrin A domains. The αI domain integrins are
only found in chordates (Johnson et al. 2009). In
vertebrates, the αI domain integrins can be further divided
into two functionally different subgroups, namely the
leukocyte integrins (αDβ2, αEβ7, αLβ2, αMβ2, and
αXβ2; for a review, see Evans et al. 2009) and the collagen
receptor integrins (α1β1, α2β1, α10β1, and α11β1; for a
review, see Heino 2007). These integrins seem to have
specialized functions related to, amongst others, native and
acquired immunity, thrombosis, and the development of
connective tissues.
Integrins anchor cells to the ECM and have an important
role in the maintenance of tissue integrity. However,
integrins are also signaling receptors (for a review, see
Legate et al. 2009). Unlike many growth factor receptors,
integrins have no enzymatic activity, and their signaling
function is dependent on their binding to intracellular
proteins. Integrin heterodimers may take alternative con-
formations in which the integrin cytoplasmic domains are
either together or separated from each other (for a review,
see Arnaout et al. 2007; Luo et al. 2007). Recent studies
have stressed the flexibility of the integrin structure and
suggest that integrins can have many different conforma-
tions and activation states (Zhu et al. 2008). The cyto-
plasmic domains of the integrin β subunits alone have been
reported to bind to tens of different cytoskeletal and
signaling proteins (for a review, see Legate and Fassler
2009). The interactions of integrin α subunits with
intracellular proteins are much less studied, but α subunits
are nevertheless thought to play an important part in
heterodimer-specific signaling events. Given the finding
that the intracellular domains are relatively short, only a
limited number of proteins can bind at any one time.
Therefore, integrins can probably gather various types of
protein complexes.
Talin is an actin-binding protein that can also recognize a
specific motif in the cytoplasmic domains of integrin β
subunits. Talin has been found to be an important activator
of integrin-ligand-binding function (Tadokoro et al. 2003).
Its binding to the tail of β subunit breaks a salt bridge
between α and β subunits and induces a conformational
change leading to the extension of the integrin ectodomain,
whereas the inactive integrin is considered to be bent.
Kindlins 1–3 bind to a distinct motif in β cytoplasmic
domain when compared with talin (Moser et al. 2009).
Kindlins act together with talin in the regulation of integrin
activity (Moser et al. 2009). Other proteins binding to β
cytoplasmic domains include the protein tyrosine kinases,
such as focal adhesion kinase, Src, and integrin-linked
kinase. These kinases and numerous other kinases, phospha-
tases, GTP-ases, and adaptor proteins can link the integrins
to downstream signaling pathways (Legate et al. 2009).
Because of its large cytoplasmic domain, β4 integrin is
considered to behave in a different manner from all other
integrin β subunits. Tyrosine kinases, such as Src family
kinases, can phosphorylate the cytoplasmic domain β4 and
create a binding site for Shc that further activates Ras and
its downstream signaling pathways (Mainiero et al. 1997;
Shaw et al. 1997).
Direct binding of integrins to growth factors
Integrins are known to regulate the same signaling path-
ways as growth factor receptors (Fig. 1). A classic example
of this is the ability of a subset of integrins to engage
ligands and subsequently activate the Shc-Ras-Mitogen-
activated protein kinase pathway in a manner similar to
growth factor receptors (Wary et al. 1996, 1998). More
recently, we have realized that some integrins may also
112 Cell Tissue Res (2010) 339:111–120bind directly to growth factors (Fig. 1). The best-known
example is αVβ6 integrin, which plays a crucial role in the
activation of transforming growth factor-β (TGF-β). The
latency-associated peptide (LAP) in latent TGF-β (LTGF-
β) has an RGD motif that can be recognized by αVβ6
integrin. The binding of LTGF-β to αVβ6 integrin leads to
the activation of the growth factor (Munger et al. 1999). In
addition, LTGF-β can be activated by plasmin (Sato and
Rifkin 1989), by metalloproteinases (Yu and Stamenkovic
2000), or by binding to thrombospondin (Crawford et al.
1998). Despite the finding that the αVβ6-mediated activa-
tion of LTGF-β represents only one of many alternative
activation mechanisms, αVβ6 seems to be critical for TGF-
β action in many animal models for fibrotic diseases. The
lack of β6 integrin makes mice resistant to pulmonary
fibrosis induced by bleomysin (Munger et al. 1999), and to
kidney (Ma et al. 2003) and biliary (Wang et al. 2007)
fibrosis. On the other hand, the overexpression of β6
integrin in mouse skin induces the spontaneous formation
of chronic wounds (Hakkinen et al. 2004). Integrin αVβ8
Fig. 1 Various forms of collaboration between integrins (green)
and growth factor receptors (blue). a Integrins may directly bind to
latent growth factors (LGF) and activate them. Subsequently,
activation growth factors (GF) can bind to their signaling receptors.
b The binding of integrins to extracellular matrix (ECM) proteins
often activates the same signaling pathways as GF binding to GF
receptors. c Receptors can signal when located either on the cell
surface or in endosomes. Co-endocytosis of integrins and GF
receptors regulates cellular signaling at multiple levels. d, e Integrins
can activate GF receptors in a collaborative or direct manner. In both
cases, integrins create an environment in which the GF receptors can
properly interact with the downstream signaling molecules. In the
collaborative mechanism, the binding of GFs to their receptors
precedes receptor activation (d), whereas in the direct mechanism,
the GF receptors are activated without ligand binding (e). f Integrins
can also activate protein tyrosine phosphatases (PTP) and suppress
signaling by GF receptors
Cell Tissue Res (2010) 339:111–120 113can also bind to LTGF-β and activate the growth factor.
The activation mechanism is reported to involve a
membrane-type matrix metalloproteinase, MT1-MMP (Mu
et al. 2002). Integrin αVβ8 is expressed on brain astrocytes
and is considered to mediate cross-talk with αVβ8-negative
endothelial cells in a TGF-β-dependent manner (Cambier et
al. 2005). The finding that αVβ8 integrin-deficient mice
have lethal defects in the development of the blood vessels
in the brain (Zhu et al. 2002) further stresses the
physiological importance of this mechanism. LTGF-β
might also be recognized by αVβ1, αVβ5 (Munger et al.
1998), αVβ3 (Asano et al. 2005), and α8β1 (Lu et al.
2002). However, the physiological relevance of these
interactions is not clear. For example, integrin αVβ1i s
abundantly expressed in various cell lines, but its existence
in tissues is uncertain.
In addition to LTGF-β, integrins can also bind to other
growth factors that regulate angiogenesis and lymphangio-
genesis. Integrin α9β1 can bind to vascular endothelial
growth factors A, C, and D (VEGF-A, -C, -D; Vlahakis et
al. 2005, 2007). The role of α9β1 seems to be critical
especially during lymphangiogenesis, since the lack of
α9β1 in the mouse prevents lymphangiogenesis (Huang et
al. 2000). VEGF-A can also be recognized by α3β1 and
αVβ3 integrins (Hutchings et al. 2003). However, these
integrins can only bind to the 165-kDa splicing varant of
VEGF-A, whereas α9β1 can also recognize the 121-kDa
variant (Vlahakis et al. 2005). Integrin binding to VEGF-A
seems to regulate endothelial cell migration, and results
from in vivo assays, such as the chick chorioallantoic
membrane assay, indicate that the interaction is relevant for
angiogenesis (Vlahakis et al. 2007). In addition to VEGFs,
angiopoietins, such as angiopoietin-1 and -2, form a further
group of growth factors required for angiogenesis. Integrin
α5β1 has been shown to recognize angiopoietin-1 and -2
proteins (Carlson et al. 2001), but the in vivo role of this
interaction is unclear.
Growth factors that can act as direct ligands for integrins
also include fibroblast growth factor-1 (FGF-1), nerve
growth factor (NGF), and two other neurotrophins. Integrin
αVβ3 has been shown to be a receptor for FGF-1 and to
modulate FGF-1 signaling through its tyrosine kinase
receptor (Mori et al. 2008). NGF, brain-derived neuro-
trophic factor, and NT3 are ligands for α9β1 integrin.
Integrin-NGF interaction stimulates cell proliferation and
migration. In addition to modulating the signaling by NGF
receptor TrkA/NTRK1, NGF binding to α9β1 may activate
integrin signaling (Staniszewska et al. 2008).
Semaphorin 7A (Sema7A, CD108) is known to regulate
axon outgrowth through β1-integrin receptors and to
contribute to the formation of the lateral olfactory tract.
Sema7A is also expressed on activated T cells and
stimulates cytokine production in monocytes and macro-
phages through α1β1 integrin (Suzuki et al. 2007). This
function of Sema7A has been reported to be based on the
ability of Sema7A to act as a direct ligand for α1β1
integrin (Suzuki et al. 2007).
The biological consequences of growth factor binding to
an integrin seem to be variable (Table 1). In the case of
LTGF-β, the obvious role of the integrin is to activate the
latent growth factor by inducing a conformational change
or presenting the latent growth factor to a protease.
Integrins may also assist the binding of a growth factor to
its receptor, or the growth factor may even activate integrin
signaling. In many experiments, cells have been allowed to
attach to cell culture wells that have been precoated with
growth factors. Under these conditions, the cells can adhere
and migrate. However, whether integrin can take advantage
of growth factors in the same manner under in vivo
conditions remains unclear.
Integrins and growth factor receptors
Integrins and growth factor receptors are known to regulate
the same signaling pathways, and together they regulate cell
differentiation, proliferation, and survival. The balance of
the various activating and inhibiting signals is considered to
determine cell fate. However, the interplay between
integrins and growth factor receptors is more complex than
the simple independent activation of the same signaling
pathways (Fig. 1). The binding of integrins to their ligands
can cause the formation of large integrin clusters (Kim et al.
2004; Miyamoto et al. 1995). In some experimental models,
inside-out integrin activation has also induced the lateral
movement of ligand-free integrins on the cell surface and
the formation of similar clusters (Cambi et al. 2006;
Connors et al. 2007). Clustered integrins also seem to
bunch together other surface receptors, including growth
factor receptors (Yamada and Even-Ram 2002). Moreover,
integrins seem to have a regulatory role in the activation of
growth factor receptors. Integrin-dependent activation of
growth factor receptors in these clusters can be either direct
or collaborative (Yamada and Even-Ram 2002). In the
collaborative mechanism, the binding of growth factors to
the growth factor receptors precedes receptor activation,
whereas the role of the integrins is to create an environment
in which the growth factor receptors can properly interact
with the downstream signaling molecules (Fig. 1). In the
direct mechanism, the integrin-mediated aggregation of
growth factor receptors induces the formation of clusters in
which the growth factor receptors are able, for example, to
phosphorylate each other. Thus, the presence of the growth
factors is not needed in the direct mechanism (Fig. 1).
One of the physiologically most relevant examples of
collaboration between integrins and growth factors is
114 Cell Tissue Res (2010) 339:111–120adhesion-dependent survival. Adherent cells are widely
known to depend on integrin-mediated adhesion for
responsiveness to growth factors. Loss of adhesion in
normal cells results in growth arrest or anoikis (detachment
induced apoptosis) attributable to impaired signaling in-
duced by growth factors and cytokines (Danen and Yamada
2001; Frisch and Francis 1994; Schwartz and Assoian
2001). The mechanisms supporting permissive signals from
integrins in normal cells seem to vary depending on the cell
type and are not fully understood. However, the described
mechanisms include the loss of PI3K-Akt pathway signal-
ing, focal adhesion kinase inactivation, the activation of Jun
N-terminal kinase, and the phosphatase-induced inactiva-
tion of protein kinase Cε (Frisch and Ruoslahti 1997;
Ivaska et al. 2003; Ruoslahti 1999). Further insight into the
co-operation between adhesion and survival has come from
studies in cancer cells. Resistance to anoikis is emerging as
a hallmark of metastatic malignancies (Liotta and Kohn
2004), and many different mechanisms have been described
to regulate the escape from anoikis. These mechanisms are
similar to those seen in drug resistance and include the
upregulation of kinases (Douma et al. 2004) and scaffold-
ing molecules (Parsons et al. 2009), the suppression of
apoptotic pathways (Simpson et al. 2008), and, recently, the
hypoxia-induced inhibition of receptor tyrosine kinase
(RTK) endocytosis (Wang et al. 2009) and the down-
regulation of α5β1 (Rohwer et al. 2008), a critical anoikis
regulator in normal epithelial cells. Ligation of integrins
results in the activation of many RTKs in the absence of a
ligand including epidermal growth factor receptor (EGFR),
insulin receptor, platelet-derived growth factor receptor
(PDGFR), VEGFR2, and Met (for a review, see Streuli
and Akhtar 2009). In many cases, this seems to involve the
induction of a direct interaction between integrins and
growth factor receptors following integrin ligation. How-
ever, this is not the case with the collaboration of α6β4 and
Met receptor. Cells expressing only Met in the absence of
α6β4 integrin are unable to respond to human growth
factor (HGF), the ligand for Met. Interestingly, the
interaction between Met and a truncated form of β4
integrin that is unable to bind laminin is sufficient to
restore HGF responses (Trusolino et al. 2001). This
demonstrates that integrins can also collaborate with RTKs
in an adhesion-independent manner.
Indeed, in most cases, integrins seem to function as
positive regulators of growth factor receptor signaling.
However, integrin α1β1 has a unique negative role in
regulating EGFR and VEGFR2 signaling (Fig. 1). In
response to adhesion to collagen, the integrin α1-subunit
cytoplasmic tail interacts with a non-receptor protein
tyrosine phosphatase TCPTP. This leads to the activation
of TCPTP spatially at the membrane and results in the
dephosphorylation of EGFR and VEGFR2 and thus
attenuation of their signaling (Mattila et al. 2005, 2008).
Studies of transgenic animals lacking expression of β4
integrin in the breast epithelium have highlighted the
importance of the integrin-RTK co-operation in cancer
initiation in vivo. Initiation and progression of breast cancer
can be studied by using a mouse model of ErbB2-induced
mammary carcinoma. When β4-integrin is deleted from the
mammary epithelium of these mice, the onset of tumors and
their invasive growth is suppressed. This is attributable to
the requirement for β4-integrin to amplify the signaling of
ErbB2 in vivo to promoter tumor progression. Even though
Table 1 Direct binding of integrins to growth factors (VEGF vascular endothelial growth factor, NGF nerve growth factor, FGF fibroblast growth
factor, NT neurotrophin)
Integrin Growth factor Physiological role Reference
α1β1 Semaphorin 7A Inflammation Suzuki et al. 2007
α3β1 VEGF-A (165) Angiogenesis Hutchings et al. 2003
α5β1 Angiopoietin-1 Angiogenesis Carlson et al. 2001
Angiopoietin-2 Angiogenesis Carlson et al. 2001
α9β1 VEGF-A (121, 165) Angiogenesis Vlahakis et al. 2007
VEGF-C, VEGF-D Lymphangiogenesis Vlahakis et al. 2005
NGF Cell proliferation Staniszewska et al. 2008
Brain-derived neurotrophic factor Staniszewska et al. 2008
NT3 Staniszewska et al. 2008
αVβ3 FGF-1 FGF signaling Mori et al. 2008
VEGF-A (165) Angiogenesis Hutchings et al. 2003
αVβ6 LTGF-β TGF-β activation. Munger et al. 1999
Fibrosis and inflammation
αVβ8 LTGF-β TGF-β activation. Cambier et al. 2005
Formation of brain blood vessels.
Cell Tissue Res (2010) 339:111–120 115ErbB2 receptor does not bind growth factors, it readily
heterodimerizes with members of the ErbB-family of RTKs
that are activated by growth factors (Bublil and Yarden
2007). Therefore, integrins probably function also to
amplify growth-factor-induced signals in vivo. Interesting-
ly, β4-integrin is necessary for ErbB2-mediated tumorigen-
esis, as mice lacking expression of β4-integrin in the
mammary epithelium show suppressed tumor onset and
invasive growth (Guo et al. 2006).
Endocytosis and recycling
Integrin endo-exocytic traffic is now widely accepted to
contribute to cell migration by supporting adhesion site
dynamics and the localized targeting of the adhesion
receptors. Integrins are constantly endocytosed from the
cell surface and are then rapidly recycled to the plasma
membrane either by the short-loop small GTPase Rab4
recycling route (in the case of αvβ3) or by the long-loop
recycling via a Rab11-positive compartment (in the case of
most β1-integrins). Integrin endocytosis has been described
via several entry routes including clathrin-dependent and -
independent pathways. These principles of integrin endo/
excocytic traffic have been review extensively and are not
discussed here in detail (Jones et al. 2006; Pellinen and
Ivaska 2006). However, recent work on integrin traffic is
revealing the complexity of the way that integrin traffic
contributes to cell motility. As is becoming obvious, the
link between migration and integrin traffic is highly cell-
context-dependent, and processes supporting cell motility
in the widely used, traditional, in vitro assays may indeed
be totally insignificant in three-dimensional and other
models that are more relevant in vivo. Small GTPases have
been shown to regulate integrin traffic in part based on their
distinct expression patterns. Rab21 small GTPase regulates
integrin endo/exocytosis by interacting with the α-subunit
of most integrins in several different cell lines (Pellinen et
al. 2006). This is important for cell migration, at least in
breast and prostate cancer cells in two dimensions. In
addition, Rab21 regulates cell anchorage and cytokinetic
furrow formation during cell division in two dimensions
(Pellinen et al. 2008). In contrast, Caswell et al. (2007)
have reported that, in epithelial ovarian carcinoma cells,
Rab25 interacts directly with the integrin β-subunit.
Interestingly, Rab25 regulates α5β1 integrin traffic spatially
in extending pseudopods, resulting in increased migration
on cell-derived matrix and increased invasion in three-
dimensional matrices, but has no effect on cell migration in
two dimensions.
Endocytosis was initially considered as a mechanism for
the downregulation of signaling by growth factor receptors
following ligand engagement. Today, spatially regulated
signaling of receptors from the endosome is well estab-
lished (Mosesson et al. 2008). Recently, growth factor
receptors and some other adhesion receptors have been
shown to regulate integrin endocytosis and vice versa
(Fig. 1). Neuropilin-1 is a transmembrane glycoprotein that
functions as an adhesion receptor and a co-receptor for both
pro- and anti-angiogenic factors (Olsson et al. 2006;
Shimizu et al. 2000). Interestingly, neuropilin-1 seems to
regulate the internalization of active α5β1 integrin in
endothelial cells and to regulate their ability to assemble
fibronectin (Valdembri et al. 2009). Recently, the expres-
sion of T-cadherin, a glycophosphatidylinositol-anchored
cadherin molecule, has also been shown to suppress the
internalization of β1-integrins, whereas the stimulation of
EGFR with EGF induces the internalization of β1-integrin
(Mukoyama et al. 2007). These studies demonstrate that
integrin endocytosis can be governed by other cell-surface
receptors. Conversely, the internalization of the junctional
adhesion molecule JAM-A has recently been shown to be
dependent on integrin internalization, and the chemotactic
migration of neutrophils requires the co-endocytosis of both
receptors (Cera et al. 2009). These examples are interesting
and suggest that the cross-talk between the various
receptors is also governed at the levels of endocytosis.
Even though integrins and growth factor receptors have
Table 2 Integrin cross-talk with other receptor systems in endosomes (VEGFR vascular endothelial growth factor receptor, EGFR epidermal
growth factor receptor, JAM-A junctional adhesion molecule-A)
Integrin Other receptors Physiological role Reference
αvβ3 Integrin α5β1 Integrin αvβ3 inhibits recycling of α5β1; reduced invasion White et al. 2007
αvβ3 EGFR Integrin αvβ3 inhibits recycling of EGFR; reduced invasion Caswell et al. 2008
α5β1 Neuroplilin-1 Neuropilin-1 induces α5β1 endocytosis Valdembri et al. 2009
β1 T-cadherin T-cadherin inhibits β1-integrin endocytosis Mukoyama et al. 2007
β1 JAM-A JAM-A internalization depends on β1-integrin endocytosis; neutrophil chemotaxis Cera et al. 2009
αVβ3 VEGFR1 VEGFR1 stimulates recycling of αvβ3; fibronectin assembly Jones et al. 2009
αVβ3, αVβ5 VEGFR2 Integrin inhibition results in increased VEGFR2 recycling and angiogenesis Reynolds et al. 2009
116 Cell Tissue Res (2010) 339:111–120been shown to co-cluster and form complexes, whether
they can also be co-endocytosed together in a ligand-
dependent or ligand-independent way remains unclear.
More progress has been made in understanding the
recycling of integrins and growth factor receptors and the
cross-talk between the various integrins. As is becoming
apparent, the trafficking of diverse cargo along distinct
endocytic pathways results in functional interdependence
whereby one pathway influences the other. Integrin αvβ3
traffics through the Rab4-positive rapid-recycling pathway.
Interestingly, this regulates the recycling of another RGD-
binding receptor α5β1 integrin. When αvβ3 is functional
and rapidly trafficking, α5β1 integrin is recycled less, and
cells migrate persistently in two dimensions (Caswell et al.
2008; White et al. 2007). However, the inhibition of αvβ3
with the small molecule antagonist cilengitide results in an
increased recycling of α5β1. This results in random
motility in two dimensions but an increased invasiveness
in three dimensions (White et al. 2007). Interestingly, α5β1
forms a complex with EGFR and Rab GTPase effector Rab-
coupling protein in the recycling endosomal compartment.
Inhibition of αvβ3 also results in increased recycling of
EGFR to the plasma membrane resulting in increased
invasion and activation of the Akt pathway (Caswell et al.
2008). EGFR has been shown to recycle when engaged
with lower affinity ligands such as TGFα (Ebner and
Derynck 1991; Waterman and Yarden 2001). However,
recent data suggest that alterations in other cellular
signaling pathways result in the recycling of other growth
factor receptors. PDFGRβ does not recycle normally.
However, it has been shown to recycle rapidly if it becomes
hyperphosphorylated upon loss of its negative regulator
TCPTP protein tyrosine phosphatase (Hellberg et al. 2009;
Karlsson et al. 2006). This has not yet been linked to
integrin traffic, but since integrin adhesion regulates
TCPTP activity (Mattila et al. 2005), and since PDGFRβ
can co-cluster and be activated without a ligand by the
integrins (Schneller et al. 1997), integrin traffic might also
regulate PDGFRβ function. In endothelial cells, intimate
cross-talk seems to occur between the trafficking of αvβ3
integrin and VEGFR1 and -2 receptors. VEGFR1 activates
the recycling of αvβ3 integrin from the Rab4-positive
compartment and is involved in regulating fibronectin
polymerization (Jones et al. 2009). Conversely, inhibition
of αvβ3 with cilengitide alters the recycling of VEGFR2,
thus promoting angiogenesis (Reynolds et al. 2009). This is
unexpected as integrin inhibitors are currently undergoing
clinical trials as anti-angiogenic agents. Thus, a new platform
for integrin and growth factors receptor co-operation and
cross-talk is emerging at the endosomal compartment
(summarized in Table 2), and future findings in this area
are likely to provide important new insights into invasion,
transformation, and the regulation of angiogenesis.
Concluding remarks
The emerging information about growth factor and cell
adhesion receptors has unveiled a multiplicity of mecha-
nisms regarding the way that the receptor systems work
together. Integrin binding to ECM proteins and growth
factor binding to their own receptors regulate many
common signaling pathways. Integrins may directly bind
to some growth factors and, in the case of TGF-β, activate
them (Munger et al. 1999). Furthermore, activated integrins
form receptor clusters that also contain growth factor
receptors. In these protein complexes, integrins are required
for the formation of a platform in which growth factor
receptors can properly interact with downstream signaling
partners (Yamada and Even-Ram 2002). Interestingly,
within the integrin-organized complexes, growth factor
receptors can be activated even without ligands. The most
recent observations have revealed a new level in the
interplay between integrins and growth factor receptors.
Previously, both receptor types were known to be internal-
ized and recycled back to the cell surface. However, current
reports indicate that integrins orchestrate the intracellular
trafficking of growth factor receptors (Caswell and Norman
2008; Caswell et al. 2008).
This new information might help to explain the
contradictory results that have generated debate during the
past few years with regard to integrin function. Especially
in the cases of αV integrins and α2β1 integrin, results
obtained in the knockout phenotypes have been in conflict
with those from experiments involving the use of integrin
inhibitors (Hynes 2002; Zhang et al. 2008). Recent
observations indicate that the lack of integrins affects the
levels of growth factor receptors on the cell surface (Zhang
et al. 2008). Furthermore, integrin inhibitors not only might
block integrin binding to ligands, but may also affect
signaling by growth factor receptors (Reynolds et al. 2009).
Thus, the new data stress the role of integrins as integral
parts of the cellular signaling machinery. Furthermore, the
direct role of specific integrins must be reconsidered in
certain biological processes, such as angiogenesis.
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